EKF Diagnostics (LON:EKF) Sets New 12-Month Low – What’s Next?

EKF Diagnostics Holdings plc (LON:EKFGet Free Report)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as GBX 23 ($0.29) and last traded at GBX 24.50 ($0.30), with a volume of 678077 shares. The stock had previously closed at GBX 24.70 ($0.31).

EKF Diagnostics Price Performance

The firm has a market capitalization of £108.90 million, a P/E ratio of 22.80 and a beta of 0.57. The company has a fifty day moving average of GBX 25.92 and a 200 day moving average of GBX 27.10. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Further Reading

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.